ログイン

SUMMATIVE EXAM #4

SUMMATIVE EXAM #4
30問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    A decreased leukocyte alkaline phosphatase (LAP) score is seen in: A. Polycythemia vera B. Chronic myelogenous leukemia C. Leukemoid reactions D. Acute myelogenous leukemia

    B. Chronic myelogenous leukemia

  • 2

    The result for a leukocyte alkaline phosphatase stain (LAP) stain is: A. Normal if the result is 32 to 182 with fast blue RR dye B. Positive, if 10 to 50% hemolysis present C. Normal, if <10% of cells exhibit hemoglobin F in adults D. Normal in newborns if the result is 70 to 90%

    A. Normal if the result is 32 to 182 with fast blue RR dye

  • 3

    The Philadelphia chromosome is formed by a translocation between: A. Chromosome 22 and chromosome 9 B. Chromosome 21 and chromosome 9 C. Chromosome 21 and chromosome 6 D. Chromosome 22 and chromosome 6

    A. Chromosome 22 and chromosome 9

  • 4

    Molecular techniques are being used to detect abnormalities of: A. Erythrocytes B. Leukocytes C. Some coagulation factors D. All of the above

    D. All of the above

  • 5

    The first inherited hematologic disorder to be diagnosed using molecular biologic assay was: A. Hemophilia A B. Factor V Leiden C. Sickle cell anemia D. CML

    C. Sickle cell anemia

  • 6

    PCR testing is useful in: A. Forensic testing B. Genetic testing C. Disease diagnosis D. All of the above

    D. All of the above

  • 7

    The method considered to be the “gold standard” of molecular methods is: A. DNA sequencing B. Southern blot C. Northern blot D. Dot blot

    A. DNA sequencing

  • 8

    The major intended purpose of the laboratory safety manual is to: A. Protect the patient and laboratory personnel B. Protect laboratory and other hospital personnel C. Comply with local health and state regulatory requirements D. Comply with OSHA regulations

    A. Protect the patient and laboratory personnel

  • 9

    The most important step in phlebotomy is: A. Cleansing the site B. Identifying the patient C. Selecting the proper needle length D. Using the correct evacuated tube

    B. Identifying the patient

  • 10

    Which of the following skin puncture areas is (are) acceptable for the collection of capillary blood from an infant? A. Previous puncture site B. Posterior curve of the heel C. The arch D. Medial or lateral plantar surface

    B. Posterior curve of the heel

  • 11

    Vein of choice for performing a venipuncture is the: A. Basilic, because it is the most prominent vein in the antecubital fossa B. Cephalic or accessory cephalic, because it is the least painful site C. Median or median cubital, because it has the lowest risk of damaging nerves in the arm D. One of the hand veins, because they are most superficial and easily accessed

    C. Median or median cubital, because it has the lowest risk of damaging nerves in the arm

  • 12

    The venipuncture needle should be inserted into the arm with the bevel facing: A. Down and an angle of insertion between 15 and 30 degrees B. Up and an angle of insertion less than 30 degrees C. Down and an angle of insertion greater than 45 degrees D. Up and an angle of insertion between 30 and 45 degrees

    B. Up and an angle of insertion less than 30 degrees

  • 13

    A blood sample is needed from a patient with IV fluids running in both arms. Which of the following is an acceptable procedure? A. Any obtainable vein is satisfactory. B. Obtain sample from above the IV site. C. Obtain sample from below the IV site with special restrictions. D. Disconnect the IV line. E. Do not draw a blood specimen.

    C. Obtain sample from below the IV site with special restrictions.

  • 14

    When encountering a patient with a fistula, the phlebotomist should: A. Apply the tourniquet below the fistula B. Use the other arm C. Collect the blood from the fistula D. Attach a syringe to the T-tube connector

    B. Use the other arm

  • 15

    An unconscious inpatient does not have an ID band. The name on an envelope on the patient’s nightstand matches with the requisition. What should you do? A. Ask the nurse to verify the patient’s ID and collect the specimen. B. Complete the required procedure and then file an incident report. C. Do not start any procedure until the nurse attaches an ID bracelet. D. Make a computer entry to will alert other phlebotomists of the issue

    C. Do not start any procedure until the nurse attaches an ID bracelet.

  • 16

    If a blood specimen is spilled on a laboratory bench or floor area, the first step in cleanup should be: A. Wear gloves and a lab coat B. Absorb blood with disposable towels C. Clean with freshly prepared 1% chlorine solution D. Wash with water

    B. Absorb blood with disposable towels

  • 17

    What is the best way to clean up blood that has dripped on the arm of a phlebotomy chair? A. Absorb it with a gauze pad and clean the area with disinfectant. B. Rub it with a damp cloth and wash the area with soap and water. C. Wait for it to dry and then scrape it into a biohazard container. D. Wipe it with an alcohol pad using an outward circular motion

    A. Absorb it with a gauze pad and clean the area with disinfectant

  • 18

    Which characteristic is inaccurate with respect to the anticoagulant K3 EDTA? A. Removes ionized calcium (Ca2+) from fresh whole blood by the process of chelation B. Is used for most routine coagulation studies C. Is the most commonly used anticoagulant in hematology D. Is conventionally placed in lavender-stoppered evacuated tubes

    B. Is used for most routine coagulation studies

  • 19

    In which of the following laboratory situations is a verbal report permissible? A. When the patient is going directly to the physician’s office and wants to have the report available B. When the report cannot be found at the nurse’s station C. When preoperative test results are needed by the anesthesiologist D. None of the above

    D. None of the above

  • 20

    If a blood smear is too long, the problem can be resolved by: A. Decreasing the angle of the pusher slide B. Increasing the angle of the pusher slide C. Using a larger drop of blood D. Pushing the slide slower in smearing out the blood

    B. Increasing the angle of the pusher slide

  • 21

    If a blood smear stains too red on microscopic examination of a Wright-stained preparation, possible causes include that: A. The staining time was too long B. The stain was too basic C. The buffer was too acidic and the exposure time was too short D. The buffer was too basic and the exposure time was too long

    C. The buffer was too acidic and the exposure time was too short

  • 22

    Hematology and hemostasis laboratory quality assurance relies on basic statistics describing: 1. Measures of central tendency 2. Measures of dispersion 3. Measures of probability A. 1 and 2 B. 1 and 3 C. 2 and 3 D. 1, 2 and 3

    A. 1 and 2

  • 23

    A. Within ±1 standard deviation of the mean B. Between 1 and 2 standard deviations of the mean C. Within ±2 standard deviations of the mean D. Within ±3 standard deviations of the mean

    C. Within ±2 standard deviations of the mean

  • 24

    Delta checks identify: A. Random error B. Shift C. Trend D. Gross error

    D. Gross error

  • 25

    The laboratory procedure manual does not need to include: A. Test method, principle of the test, and clinical applications B. Specimen collection and storage procedures C. The name of the supplier of common laboratory chemicals D. QC techniques, procedures, normal values, and technical sources of error

    C. The name of the supplier of common laboratory chemicals

  • 26

    The most important practice in preventing the spread of disease is: A. Wearing masks during patient contact B. Proper hand washing C. Wearing disposable laboratory coats D. Identifying specimens from known or suspected HIV- and HBV-infected patients with a red label

    B. Proper hand washing

  • 27

    Where should alcohol and other flammable chemicals be stored? A. In an approved safety can or storage cabinet away from heat sources B. Under a hood and arranged alphabetically for ease of identification in an emergency C. In a refrigerator at 28 C to 88 C to reduce volatilization D. On a low shelf in an area protected from light

    A. In an approved safety can or storage cabinet away from heat sources

  • 28

    . A cloudy and turbid CSF specimen is most commonly caused by: A. Increased fibrinogen B. Subarachnoid hemorrhage C. Subarachnoid hemorrhage, more than 12 hours after the bleed D. Increased number of leukocytes

    D. Increased number of leukocytes

  • 29

    A xanthochromic (yellow color) CSF specimen is most commonly caused by: A. Increased fibrinogen B. Subarachnoid hemorrhage C. Subarachnoid hemorrhage, more than 12 hours after the bleed D. Increased number of leukocytes

    C. Subarachnoid hemorrhage, more than 12 hours after the bleed

  • 30

    A grossly bloody CSF specimen is most commonly caused by: A. Increased fibrinogen B. Subarachnoid hemorrhage C. Subarachnoid hemorrhage, more than 12 hours after the bleed D. Increased number of leukocytes

    B. Subarachnoid hemorrhage

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    A decreased leukocyte alkaline phosphatase (LAP) score is seen in: A. Polycythemia vera B. Chronic myelogenous leukemia C. Leukemoid reactions D. Acute myelogenous leukemia

    B. Chronic myelogenous leukemia

  • 2

    The result for a leukocyte alkaline phosphatase stain (LAP) stain is: A. Normal if the result is 32 to 182 with fast blue RR dye B. Positive, if 10 to 50% hemolysis present C. Normal, if <10% of cells exhibit hemoglobin F in adults D. Normal in newborns if the result is 70 to 90%

    A. Normal if the result is 32 to 182 with fast blue RR dye

  • 3

    The Philadelphia chromosome is formed by a translocation between: A. Chromosome 22 and chromosome 9 B. Chromosome 21 and chromosome 9 C. Chromosome 21 and chromosome 6 D. Chromosome 22 and chromosome 6

    A. Chromosome 22 and chromosome 9

  • 4

    Molecular techniques are being used to detect abnormalities of: A. Erythrocytes B. Leukocytes C. Some coagulation factors D. All of the above

    D. All of the above

  • 5

    The first inherited hematologic disorder to be diagnosed using molecular biologic assay was: A. Hemophilia A B. Factor V Leiden C. Sickle cell anemia D. CML

    C. Sickle cell anemia

  • 6

    PCR testing is useful in: A. Forensic testing B. Genetic testing C. Disease diagnosis D. All of the above

    D. All of the above

  • 7

    The method considered to be the “gold standard” of molecular methods is: A. DNA sequencing B. Southern blot C. Northern blot D. Dot blot

    A. DNA sequencing

  • 8

    The major intended purpose of the laboratory safety manual is to: A. Protect the patient and laboratory personnel B. Protect laboratory and other hospital personnel C. Comply with local health and state regulatory requirements D. Comply with OSHA regulations

    A. Protect the patient and laboratory personnel

  • 9

    The most important step in phlebotomy is: A. Cleansing the site B. Identifying the patient C. Selecting the proper needle length D. Using the correct evacuated tube

    B. Identifying the patient

  • 10

    Which of the following skin puncture areas is (are) acceptable for the collection of capillary blood from an infant? A. Previous puncture site B. Posterior curve of the heel C. The arch D. Medial or lateral plantar surface

    B. Posterior curve of the heel

  • 11

    Vein of choice for performing a venipuncture is the: A. Basilic, because it is the most prominent vein in the antecubital fossa B. Cephalic or accessory cephalic, because it is the least painful site C. Median or median cubital, because it has the lowest risk of damaging nerves in the arm D. One of the hand veins, because they are most superficial and easily accessed

    C. Median or median cubital, because it has the lowest risk of damaging nerves in the arm

  • 12

    The venipuncture needle should be inserted into the arm with the bevel facing: A. Down and an angle of insertion between 15 and 30 degrees B. Up and an angle of insertion less than 30 degrees C. Down and an angle of insertion greater than 45 degrees D. Up and an angle of insertion between 30 and 45 degrees

    B. Up and an angle of insertion less than 30 degrees

  • 13

    A blood sample is needed from a patient with IV fluids running in both arms. Which of the following is an acceptable procedure? A. Any obtainable vein is satisfactory. B. Obtain sample from above the IV site. C. Obtain sample from below the IV site with special restrictions. D. Disconnect the IV line. E. Do not draw a blood specimen.

    C. Obtain sample from below the IV site with special restrictions.

  • 14

    When encountering a patient with a fistula, the phlebotomist should: A. Apply the tourniquet below the fistula B. Use the other arm C. Collect the blood from the fistula D. Attach a syringe to the T-tube connector

    B. Use the other arm

  • 15

    An unconscious inpatient does not have an ID band. The name on an envelope on the patient’s nightstand matches with the requisition. What should you do? A. Ask the nurse to verify the patient’s ID and collect the specimen. B. Complete the required procedure and then file an incident report. C. Do not start any procedure until the nurse attaches an ID bracelet. D. Make a computer entry to will alert other phlebotomists of the issue

    C. Do not start any procedure until the nurse attaches an ID bracelet.

  • 16

    If a blood specimen is spilled on a laboratory bench or floor area, the first step in cleanup should be: A. Wear gloves and a lab coat B. Absorb blood with disposable towels C. Clean with freshly prepared 1% chlorine solution D. Wash with water

    B. Absorb blood with disposable towels

  • 17

    What is the best way to clean up blood that has dripped on the arm of a phlebotomy chair? A. Absorb it with a gauze pad and clean the area with disinfectant. B. Rub it with a damp cloth and wash the area with soap and water. C. Wait for it to dry and then scrape it into a biohazard container. D. Wipe it with an alcohol pad using an outward circular motion

    A. Absorb it with a gauze pad and clean the area with disinfectant

  • 18

    Which characteristic is inaccurate with respect to the anticoagulant K3 EDTA? A. Removes ionized calcium (Ca2+) from fresh whole blood by the process of chelation B. Is used for most routine coagulation studies C. Is the most commonly used anticoagulant in hematology D. Is conventionally placed in lavender-stoppered evacuated tubes

    B. Is used for most routine coagulation studies

  • 19

    In which of the following laboratory situations is a verbal report permissible? A. When the patient is going directly to the physician’s office and wants to have the report available B. When the report cannot be found at the nurse’s station C. When preoperative test results are needed by the anesthesiologist D. None of the above

    D. None of the above

  • 20

    If a blood smear is too long, the problem can be resolved by: A. Decreasing the angle of the pusher slide B. Increasing the angle of the pusher slide C. Using a larger drop of blood D. Pushing the slide slower in smearing out the blood

    B. Increasing the angle of the pusher slide

  • 21

    If a blood smear stains too red on microscopic examination of a Wright-stained preparation, possible causes include that: A. The staining time was too long B. The stain was too basic C. The buffer was too acidic and the exposure time was too short D. The buffer was too basic and the exposure time was too long

    C. The buffer was too acidic and the exposure time was too short

  • 22

    Hematology and hemostasis laboratory quality assurance relies on basic statistics describing: 1. Measures of central tendency 2. Measures of dispersion 3. Measures of probability A. 1 and 2 B. 1 and 3 C. 2 and 3 D. 1, 2 and 3

    A. 1 and 2

  • 23

    A. Within ±1 standard deviation of the mean B. Between 1 and 2 standard deviations of the mean C. Within ±2 standard deviations of the mean D. Within ±3 standard deviations of the mean

    C. Within ±2 standard deviations of the mean

  • 24

    Delta checks identify: A. Random error B. Shift C. Trend D. Gross error

    D. Gross error

  • 25

    The laboratory procedure manual does not need to include: A. Test method, principle of the test, and clinical applications B. Specimen collection and storage procedures C. The name of the supplier of common laboratory chemicals D. QC techniques, procedures, normal values, and technical sources of error

    C. The name of the supplier of common laboratory chemicals

  • 26

    The most important practice in preventing the spread of disease is: A. Wearing masks during patient contact B. Proper hand washing C. Wearing disposable laboratory coats D. Identifying specimens from known or suspected HIV- and HBV-infected patients with a red label

    B. Proper hand washing

  • 27

    Where should alcohol and other flammable chemicals be stored? A. In an approved safety can or storage cabinet away from heat sources B. Under a hood and arranged alphabetically for ease of identification in an emergency C. In a refrigerator at 28 C to 88 C to reduce volatilization D. On a low shelf in an area protected from light

    A. In an approved safety can or storage cabinet away from heat sources

  • 28

    . A cloudy and turbid CSF specimen is most commonly caused by: A. Increased fibrinogen B. Subarachnoid hemorrhage C. Subarachnoid hemorrhage, more than 12 hours after the bleed D. Increased number of leukocytes

    D. Increased number of leukocytes

  • 29

    A xanthochromic (yellow color) CSF specimen is most commonly caused by: A. Increased fibrinogen B. Subarachnoid hemorrhage C. Subarachnoid hemorrhage, more than 12 hours after the bleed D. Increased number of leukocytes

    C. Subarachnoid hemorrhage, more than 12 hours after the bleed

  • 30

    A grossly bloody CSF specimen is most commonly caused by: A. Increased fibrinogen B. Subarachnoid hemorrhage C. Subarachnoid hemorrhage, more than 12 hours after the bleed D. Increased number of leukocytes

    B. Subarachnoid hemorrhage